Menu

Whitethorn For House

Politics For All Parties

Family Man turned CEO of Ovations Pharmaceuticals LLC: Jeff Aronin

How Jeff Aronin Chartered Innovation Through Paragon Biosciences: Recap

 

Jeff Aronin is an individual that eventually would have to make an ultimate decision on how to treat his patients ailments. He had a child in his care who was suffering from seizures. The choice between treating this condition with surgery (that could be a rough recovery) or a medication was a tough call to make. Aronin eventually decided to go the route of medication to avoid the possible complications due to surgery. Jeff Aronin believes that building a relationship with his patients is very crucial step to further his career. It’s his patients that motivated him to become the Chief Executive Officer and creator of Ovations Pharmaceuticals LLC.

 

In the beginning Jeff Aronin received his Bachelors Degree through Northern Illinois University. He later obtained his Masters of Business Administration through DePaul University. He soon began a career in the healthcare field. He later discovered he could better help people obtain the medication they needed through the pharmaceutical industry. He created Ovations Pharmaceuticals LLC in the early 2000’s. He wanted to be able to fully focus his career on drug development and the patients needs. What was going to make his pharmaceutical company stand out from others was that his focus was to address the specific needs of the patients. Especially the patients who had rare diseases or diseases with little to no cure. He wanted to be able to make a difference for those people.

 

In 2009 a Danish company named Lundbeck offered to buy Aronin’s pharmaceutical company for just under one billion dollars. Lundbeck decided the smart thing to do was to continue allowing Aronin to be the CEO of Ovations Pharmaceuticals LLC. This company still continues to be a huge success story and to think it’s all because of a physician who wanted to make a difference in the treatment of his patients.